Key result
Higher CTI linked to ~52% higher odds of arterial stiffness per unit increase in prediabetes.
Why the study?
Prediabetes accelerates arterial stiffening, but the optimal metabolic biomarker for vascular assessment remains undetermined.
Do higher levels of HOMA-IR, TyG, and CTI predict prevalent arterial stiffness in prediabetic adults?
Cross-Sectional (n=2,008)
No
Do higher levels of HOMA-IR, TyG, and CTI predict prevalent arterial stiffness in prediabetic adults?
TyG and CTI are robust, accessible surrogate markers that outperform HOMA-IR in identifying prevalent arterial stiffness in individuals with prediabetes.
Arterial stiffness association with insulin resistance should not change practice; cross-sectional data leaves open causality and prospective validation.
Prediabetes accelerates arterial stiffening, yet the optimal metabolic biomarker for vascular assessment remains undetermined. This study investigated the associations of the homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride-glucose (TyG) index, and C-reactive protein-triglyceride-glucose index (CTI) with arterial stiffness in a prediabetic population. This cross-sectional study enrolled 2,008 prediabetic adults. Arterial stiffness was defined by brachial-ankle pulse wave velocity (baPWV). Multivariable logistic regression, restricted cubic spline (RCS) modeling, and ROC curve analyses were employed to evaluate and compare the discriminatory performance of HOMA-IR, TyG, and CTI. All three indices were independently associated with arterial stiffness. Fully adjusted odds ratios (ORs) per one-unit increment were 1.12 (1.04–1.21) for HOMA-IR, 1.49 (1.24–1.80) for TyG, and 1.52 (1.25–1.85) for CTI. Comparing the highest to the lowest quartiles, the ORs for arterial stiffness were 1.84 ( 1.31–2.59) for HOMA-IR, 2.02 (1.44–2.82) for TyG, and 1.72 (1.23–2.39) for CTI, respectively. RCS analysis revealed a nonlinear relationship for HOMA-IR, whereas TyG and CTI exhibited linear dose-response patterns. ROC analyses based on adjusted prediction models showed that CTI had the numerically highest discriminatory performance (AUC = 0.790), followed closely by TyG (AUC = 0.784), whereas HOMA-IR showed lower discrimination (AUC = 0.737). Pairwise DeLong tests showed that CTI provided a modest but statistically significant improvement over TyG ( P = 0.041), while both CTI and TyG significantly outperformed HOMA-IR (both P < 0.001). Findings remained robust across subgroup and sensitivity analyses. HOMA-IR, TyG, and CTI are independent risk indicators for arterial stiffness in prediabetes. Notably, TyG and CTI exhibit stronger associations and superior discriminatory utility compared to HOMA-IR. These simple, accessible metabolic indices—particularly TyG and CTI—serve as robust practical surrogate markers for identifying prevalent arterial stiffness in individuals with prediabetes.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2026) conducted a cross-sectional in Prediabetes (n=2,008). C-reactive protein-triglyceride-glucose index (CTI) vs. Lower CTI levels was evaluated on Prevalent arterial stiffness (defined as brachial-ankle pulse wave velocity ≥ 1400 cm/s) (OR 1.52, 95% CI 1.25-1.85, p=<0.001). Higher levels of the C-reactive protein-triglyceride-glucose index (CTI) were independently associated with prevalent arterial stiffness in prediabetes, with an adjusted OR of 1.52 per one-unit increment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: